Shanghai Junshi Biosciences Co., Ltd. is a prominent biopharmaceutical company based in China, engaged in the research, development, and commercialization of innovative therapeutics for a range of dis... Shanghai Junshi Biosciences Co., Ltd. is a prominent biopharmaceutical company based in China, engaged in the research, development, and commercialization of innovative therapeutics for a range of diseases. The company's primary focus lies in the discovery and production of novel antibodies and biologics aimed at treating cancer, autoimmune, metabolic, and infectious diseases. As a key player in China's rapidly advancing biotech industry, Shanghai Junshi Biosciences is known for leveraging cutting-edge technologies such as monoclonal antibodies and bispecific antibodies in its product development pipeline. Through strategic collaborations and partnerships with global pharmaceutical firms, the company enhances its R&D capabilities and extends its reach beyond domestic borders. With a commitment to addressing unmet medical needs, Shanghai Junshi Biosciences plays a vital role in the healthcare and life sciences sectors, offering potential groundbreaking treatments and contributing significantly to the global biotech landscape.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Shanghai Junshi Biosciences is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Shanghai Junshi Biosciences is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Shanghai Junshi Biosciences's data?

Start your 30-day free trial to request a data review for Shanghai Junshi Biosciences.

Start Free Trial

Legal Center Contact Us